Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ITCI Intra Cellular Therapies Inc

83,72

-0,52 (-0,62%)

04 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Intra Cellular Therapies Charts.

Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Intra Cellular Therapies Charts.

News Intra Cellular Therapies Inc

Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting
Mittwoch 11 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 7 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 5 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 4 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 3 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Intra-Cellular Therapies Submits Supplemental New Drug Application (sNDA) to FDA for CAPLYTA® (lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive Therapy
Dienstag 3 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
Dienstag 19 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 8 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress
Donnerstag 7 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 5 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia
Dienstag 5 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 30 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Intra Cellular Therapies Inc News-Artikel

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen